Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cellectis S.A. ADR
(NQ:
CLLS
)
2.400
UNCHANGED
Streaming Delayed Price
Updated: 2:25 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cellectis S.A. ADR
< Previous
1
2
3
4
Next >
7 CRISPR Stocks With the Best Long-Term Potential
January 30, 2023
CRISPR stocks are becoming commercially viable leading to substantial returns in 2023 and beyond, as the technology will only improve.
Via
InvestorPlace
Why Is Calyxt (CLXT) Stock Up 140% Today?
January 17, 2023
Calyxt (CLXT) stock is rocketing higher on Tuesday after the company signed an all-stock merger agreement with Cibus Global.
Via
InvestorPlace
5 Most Expensive Health Care Stocks You Should Worry About
January 12, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket
January 03, 2023
Gainers
Via
Benzinga
Cellectis Touts Positive Preliminary Data From Two Leukemia Trials
December 13, 2022
Via
Benzinga
Iovance Receives FDA Allowance For IOV-4001 Study In Two Advanced Cancers
March 16, 2022
Via
Benzinga
Recap: Cellectis Q4 Earnings
March 03, 2022
Cellectis (NASDAQ:CLLS) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Cellectis...
Via
Benzinga
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 03, 2023
Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group.
Via
Benzinga
Crispr Stock In 2023: Will Down-In-The-Dumps Shares Sparkle Again In 2023?
December 22, 2022
Crispr and Vertex are working toward the first submissions for a CRISPR-based product.
Via
Investor's Business Daily
Cellectis's Earnings Outlook
November 02, 2022
Cellectis (NASDAQ:CLLS) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Cellectis will...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
February 04, 2022
On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...
Via
Benzinga
Why Missfresh Shares Are Trading Lower; Here Are 30 Stocks Moving Premarket
October 10, 2022
Gainers M-tron Industries, Inc. (NASDAQ: MPTI) rose 57.9% to $24.00 in pre-market trading after surging 10% on Friday. M-tron Industries completed its earlier announced separation from The LGL Group,...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 07, 2022
Gainers Akanda (NASDAQ:AKAN) stock rose 27.1% to $0.52 during Friday's pre-market session. The company's market cap stands at $16.0 million.
Via
Benzinga
11 Health Care Stocks Moving In Friday's Pre-Market Session
September 23, 2022
Gainers Rubius Therapeutics (NASDAQ:RUBY) shares moved upwards by 30.46% to $0.59. The market value of their outstanding shares is at $53.5 million.
Via
Benzinga
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
September 26, 2022
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.
Via
Benzinga
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
September 23, 2022
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day...
Via
Benzinga
Why T2 Biosystems Is Trading Higher By 18%; Here Are 28 Stocks Moving Premarket
September 23, 2022
Gainers HHG Capital Corporation (NASDAQ: HHGC) shares rose 42.1% to $14.56 in pre-market trading.
Via
Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 01, 2022
Via
Benzinga
Cellectis Gets FDA Nod For Initial-Stage Non-Hodgkin Lymphoma Study
August 01, 2022
The U.S. Food and Drug Administration (FDA) has announced clearance to Cellectis' (NASDAQ: CLLS) Investigational New Drug (IND) application to initiate a Phase 1/2a clinical trial of UCART20x22 for...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 14, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 22, 2022
Via
Benzinga
71 Biggest Movers From Yesterday
May 20, 2022
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation...
Via
Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
May 19, 2022
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022
May 18, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 17, 2022
Via
Benzinga
Natural Killer Cell Therapy Focused-Cytovia Turns To SPAC Merger For Public Market Debut
April 27, 2022
Via
Benzinga
Cellectis Reveals Preclinical Data On First Allogeneic Dual CAR T-Cell Product In Non-Hodgkin Lymphoma
April 11, 2022
Via
Benzinga
A Preview Of Cellectis's Earnings
March 02, 2022
Cellectis (NASDAQ:CLLS) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
Earnings Scheduled For March 3, 2022
March 03, 2022
Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.